Maritess Esguerra | Principal Pharmacovigilance Process Leader

Maritess Esguerra, Principal Pharmacovigilance Process Leader, Genentech

Maritess Esguerra has been in the pharmaceutical and biotechnology industry for 18 years, most recently as a Principal Pharmacovigilance Process Lead at Genentech, a member of the Roche group, where she has served as process owner (for both reference safety information and signal management) and lead for their respective tools. She has extensive experience in drug safety covering numerous product types (innovators, generics, biosimilar, and drug-device combination) in various therapeutic areas from investigational stage to post-market settings. Previously, Maritess had a progressive career and held various global and regional positions at Alliance Pharmaceutical, Chugai Pharma USA, Amgen, and Puma Biotechnology. Prior to joining the industry, Maritess started her clinical trial experience at an investigator’s site and had also conducted epidemiological and pre-clinical research.


Drug Safety World Day 1 @ 12:30


10) Reference Safety Information- RSI used in Clinical Trials based on the CTFG RSI Q&A Document and the EFPIA Draft Paper in response to such document

back to speakers